TAOX
TAO Synergies Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
−4.07%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$13
- Revenue estimate
- $88.6K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.83
- EPS estimate
- -$13
- Revenue actual
- $88.6K
- Revenue estimate
- $88.6K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +91.0%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026